Sol Gel Technologies Ltd

NASDAQ:SLGL USA Biotechnology
Market Cap
$209.88 Million
Market Cap Rank
#22115 Global
#7848 in USA
Share Price
$75.34
Change (1 day)
-5.53%
52-Week Range
$0.41 - $97.97
All Time High
$97.97
About

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopust… Read more

Sol Gel Technologies Ltd (SLGL) - Total Liabilities

Latest total liabilities as of September 2025: $8.56 Million USD

Based on the latest financial reports, Sol Gel Technologies Ltd (SLGL) has total liabilities worth $8.56 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sol Gel Technologies Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Sol Gel Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Sol Gel Technologies Ltd Competitors by Total Liabilities

The table below lists competitors of Sol Gel Technologies Ltd ranked by their total liabilities.

Company Country Total Liabilities
Kangda International Environmental Company Limited
STU:27K
Germany €12.92 Billion
Turnkey Communication Services PCL
BK:TKC
Thailand ฿2.39 Billion
FTAC Emerald Acquisition Corp.
NASDAQ:FLDDU
USA $7.56 Million
Progress-Werk Oberkirch AG
XETRA:PWO
Germany €271.95 Million
Century Lithium Corp.
V:LCE
Canada CA$410.07K
Max India Limited
NSE:MAXIND
India ₹3.71 Billion
GoldMoney Inc
PINK:XAUMF
USA $190.67 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Sol Gel Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.15 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.33 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.25 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sol Gel Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sol Gel Technologies Ltd (2014–2024)

The table below shows the annual total liabilities of Sol Gel Technologies Ltd from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 $7.00 Million +5.31%
2023-12-31 $6.64 Million +50.46%
2022-12-31 $4.42 Million -67.52%
2021-12-31 $13.60 Million +63.56%
2020-12-31 $8.31 Million -5.93%
2019-12-31 $8.84 Million +53.06%
2018-12-31 $5.77 Million -91.51%
2017-12-31 $68.01 Million +60.71%
2016-12-31 $42.32 Million +114.16%
2015-12-31 $19.76 Million +323.99%
2014-12-31 $4.66 Million --